News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH

December 6, 2016

Affimed to Present at the Jefferies 2016 London Healthcare Conference

November 9, 2016

Affimed to Present Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH

November 8, 2016

Affimed Reports Financial Results for Third Quarter 2016

November 2, 2016

Affimed to Present at the Credit Suisse 25th Annual Healthcare Conference

October 31, 2016

Affimed Announces Third Quarter 2016 Financial Results and Corporate Update Conference Call

October 26, 2016

Affimed Presents Preclinical Data on Lead Candidate AFM13 at the Annual Meeting of the Society for Natural Immunity

October 4, 2016

Affimed to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 22, 2016

Affimed to Present at Upcoming Investor Conferences

September 1, 2016

Affimed Reports Financial Results for Second Quarter 2016 and Provides Corporate Update

August 10, 2016

Affimed Announces Second Quarter 2016 Financial Results and Corporate Update Conference Call

August 3, 2016

Affimed to Present at the Jefferies 2016 Healthcare Conference

May 31, 2016

Affimed Announces Annual General Meeting of Shareholders

May 23, 2016

Affimed Reports Financial Results for First Quarter 2016

May 18, 2016

Affimed to Present at the UBS Global Healthcare Conference –New York

May 17, 2016

Affimed to Present at the Cowen and Company 36th Annual Health Care Conference

February 29, 2016

Affimed to Speak at Symposium on Emerging Approaches in Cancer Immunotherapy

February 22, 2016

Affimed to Present at the Leerink Partners 5th Annual Global Healthcare Conference

February 4, 2016

Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Hodgkin Lymphoma

January 25, 2016

Affimed Appoints Dr. Joerg Windisch as Chief Operating Officer and Adds Dr. Bernhard Ehmer to Supervisory Board

January 21, 2016

1
2
3
4
5
6
7

Events

All

Scientific

Investors

20Mar

Innate Killer Summit 2019

March 20 - 21, 2019 (San Diego, USA)
Presenter: Martin Treder

29Mar

AACR Annual Meeting 2019

March 29 - April 3, 2019 (Georgia, USA)

Webcasts of past events
All past events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.